Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily J Hanan

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|October 16, 2012
Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitorsEmily J Hanan, Anne van Abbema, Kathy Barrett, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2020
Optimization of globomycin analogs as novel gram-negative antibioticsKeira Garland, Homer Pantua, Marie-Gabrielle Braun, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutationEmily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonistsMin Zhong, Wang Shen, Kenneth J Barr, et al.
Journal of Medicinal Chemistry|October 13, 2015
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case StudyRobert Heald, Krista K Bowman, Marian C Bryan, et al.
Cancer Discovery|September 21, 2021
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) EfficacyKyung W Song, Kyle A Edgar, Emily J Hanan, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signalingMark Zak, Emily J Hanan, Patrick Lupardus, et al.
Nature|August 14, 2020
Structure of the essential inner membrane lipopolysaccharide-PbgA complexThomas Clairfeuille, Kerry R Buchholz, Qingling Li, et al.
Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor InhibitorBryan K Chan, Emily J Hanan, Krista K Bowman, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Discovery of a potent and selective aurora kinase inhibitorJohan D Oslob, Michael J Romanowski, Darin A Allen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|October 16, 2012
Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitorsEmily J Hanan, Anne van Abbema, Kathy Barrett, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2020
Optimization of globomycin analogs as novel gram-negative antibioticsKeira Garland, Homer Pantua, Marie-Gabrielle Braun, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutationEmily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonistsMin Zhong, Wang Shen, Kenneth J Barr, et al.
Journal of Medicinal Chemistry|October 13, 2015
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case StudyRobert Heald, Krista K Bowman, Marian C Bryan, et al.
Cancer Discovery|September 21, 2021
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) EfficacyKyung W Song, Kyle A Edgar, Emily J Hanan, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signalingMark Zak, Emily J Hanan, Patrick Lupardus, et al.
Nature|August 14, 2020
Structure of the essential inner membrane lipopolysaccharide-PbgA complexThomas Clairfeuille, Kerry R Buchholz, Qingling Li, et al.
Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor InhibitorBryan K Chan, Emily J Hanan, Krista K Bowman, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Discovery of a potent and selective aurora kinase inhibitorJohan D Oslob, Michael J Romanowski, Darin A Allen, et al.
Pageof 3